Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px
Document › Details

Agilent Technologies Inc.. (9/5/19). "Press Release: Agilent Technologies Announces Proposed Offering of Senior Notes". Santa Clara, CA.

Products Product investment banking
  Product 2 analytical instrument
Index term Index term Agilent–SEVERAL: credit, 201909–202909 public offering $500m net $492.8m Senior Notes 2.75% due Sept 2029
Person Person Dhingra, Ankur (Agilent 201903 IR)
     


Agilent Technologies Inc. (NYSE:A) today announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the Securities and Exchange Commission. Actual terms of the notes, including interest rate, principal amount and maturity, will depend on market conditions at the time of pricing.

Agilent intends to use the net proceeds from the offering and, to the extent necessary, cash on hand, to fund the redemption of its outstanding 5.00% senior notes due 2020 and to use any remaining proceeds for general corporate purposes.

Barclays Capital Inc., J.P. Morgan Securities LLC and MUFG Securities Americas Inc. are acting as joint book-running managers.

The offering of securities may be made only by means of a prospectus supplement and accompanying prospectus. Copies of the prospectus supplement and the accompanying prospectus can be obtained from:

Barclays Capital Inc.
745 Seventh Avenue
New York, NY 10019
Telephone: (888) 603-5847

J.P. Morgan Securities LLC
383 Madison Avenue
New York, NY 10179
Telephone: (212) 834-4533

MUFG Securities Americas Inc.
1221 Avenue of the Americas, 6th Floor
New York, NY 10020-1001
Telephone: (877) 649-6848

Electronic copies of the prospectus supplement and accompanying prospectus are or will be available for free by visiting EDGAR on the Securities and Exchange Commission website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions.


Forward-Looking Statements

This release contains "forward-looking statements " within the meaning of the federal securities laws, including with respect to our proposed senior notes offering and the anticipated use of the net proceeds therefrom. Forward-looking statements are typically identified by words or phrases such as "will, " "anticipate, " "estimate, " "expect, " "project, " "intend, " "plan, " "believe, " "target, " "forecast, " and other words and terms of similar meaning. These statements are subject to significant risks and uncertainties, including, without limitation, risks and uncertainties related to economic, market or business conditions and satisfaction of customary closing conditions related to the public offering. No assurance can be given that the securities offering discussed above will be consummated on the terms described or at all. Except as required by law, we expressly disclaim any obligation to publicly revise any forward-looking statements contained in this news release to reflect the occurrence of events after the date of this news release.


Investor Contact

Ankur Dhingra
Agilent Technologies
+1 408 345 8948
ankur_dhingra@agilent.com

   
Record changed: 2019-09-19

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px




» top